These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 22149711)

  • 1. Brucella melitensis Rev1Δwzm: Placental pathogenesis studies and safety in pregnant ewes.
    Poveda-Urkixo I; Mena-Bueno S; Ramírez GA; Zabalza-Baranguá A; Tsolis RM; Grilló MJ
    Vaccine; 2024 Jun; 42(17):3710-3720. PubMed ID: 38755066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Brucella melitensis H38ΔwbkF rough mutant protects against Brucella ovis in rams.
    Muñoz PM; Conde-Álvarez R; Andrés-Barranco S; de Miguel MJ; Zúñiga-Ripa A; Aragón-Aranda B; Salvador-Bescós M; Martínez-Gómez E; Iriarte M; Barberán M; Vizcaíno N; Moriyón I; Blasco JM
    Vet Res; 2022 Mar; 53(1):16. PubMed ID: 35236406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brucella ovis mutant in ABC transporter protects against Brucella canis infection in mice and it is safe for dogs.
    Eckstein C; Mol JPS; Costa FB; Nunes PP; Lima PA; Melo MM; Carvalho TP; Santos DO; Silva MF; Carvalho TF; Costa LF; Melo Júnior OAO; Giunchette RC; Paixão TA; Santos RL
    PLoS One; 2020; 15(4):e0231893. PubMed ID: 32298378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and trial of vaccines against
    Lalsiamthara J; Lee JH
    J Vet Sci; 2017 Aug; 18(S1):281-290. PubMed ID: 28859268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rev1Δwzm vaccine candidate is safe in young and adult sheep and protects against Brucella ovis infection in rams.
    Mena-Bueno S; Garrido V; Romero F; Zabalza-Baranguá A; Grilló MJ
    Vaccine; 2024 Sep; 42(22):125998. PubMed ID: 38806353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brucellae as resilient intracellular pathogens: epidemiology, host-pathogen interaction, recent genomics and proteomics approaches, and future perspectives.
    Dawood AS; Elrashedy A; Nayel M; Salama A; Guo A; Zhao G; Algharib SA; Zaghawa A; Zubair M; Elsify A; Mousa W; Luo W
    Front Vet Sci; 2023; 10():1255239. PubMed ID: 37876633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular Lesions in Brucella Infection: A Review of the Literature.
    Ma C; Li H; Lu S; Li X; Wang S; Wang W
    Infect Drug Resist; 2022; 15():7601-7617. PubMed ID: 36579126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome Sequencing and Comparative Genomics of Indian Isolates of
    Karthik K; Anbazhagan S; Thomas P; Ananda Chitra M; Senthilkumar TMA; Sridhar R; Dhinakar Raj G
    Front Microbiol; 2021; 12():698069. PubMed ID: 34489888
    [No Abstract]   [Full Text] [Related]  

  • 9. Disruption of pyruvate phosphate dikinase in Brucella ovis PA CO
    Vizcaíno N; Pérez-Etayo L; Conde-Álvarez R; Iriarte M; Moriyón I; Zúñiga-Ripa A
    Vet Res; 2020 Aug; 51(1):101. PubMed ID: 32795361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xyloglucan based mucosal nanovaccine for immunological protection against brucellosis developed by supercritical fluid technology.
    Vyas S; Dhoble S; Ghodake V; Patravale V
    Int J Pharm X; 2020 Dec; 2():100053. PubMed ID: 32776000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CO
    Pérez-Etayo L; de Miguel MJ; Conde-Álvarez R; Muñoz PM; Khames M; Iriarte M; Moriyón I; Zúñiga-Ripa A
    Vet Res; 2018 Sep; 49(1):85. PubMed ID: 30185220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutants in the lipopolysaccharide of Brucella ovis are attenuated and protect against B. ovis infection in mice.
    Soler-Lloréns P; Gil-Ramírez Y; Zabalza-Baranguá A; Iriarte M; Conde-Álvarez R; Zúñiga-Ripa A; San Román B; Zygmunt MS; Vizcaíno N; Cloeckaert A; Grilló MJ; Moriyón I; López-Goñi I
    Vet Res; 2014 Jul; 45(1):72. PubMed ID: 25029920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A history of the development of Brucella vaccines.
    Avila-Calderón ED; Lopez-Merino A; Sriranganathan N; Boyle SM; Contreras-Rodríguez A
    Biomed Res Int; 2013; 2013():743509. PubMed ID: 23862154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acellular vaccines for ovine brucellosis: a safer alternative against a worldwide disease.
    Martins Rda C; Irache JM; Gamazo C
    Expert Rev Vaccines; 2012 Jan; 11(1):87-95. PubMed ID: 22149711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of particulate acellular vaccines against Brucella ovis infection in rams.
    Da Costa Martins R; Irache JM; Blasco JM; Muñoz MP; Marín CM; Jesús Grilló M; Jesús De Miguel M; Barberán M; Gamazo C
    Vaccine; 2010 Apr; 28(17):3038-46. PubMed ID: 19887131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine Candidate Brucella melitensis 16M
    Hensel ME; Garcia-Gonzalez DG; Chaki SP; Hartwig A; Gordy PW; Bowen R; Ficht TA; Arenas-Gamboa AM
    mSphere; 2020 May; 5(3):. PubMed ID: 32404509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual virulence and immunogenicity of CGV26 and CGV2631 B. melitensis Rev. 1 deletion mutant strains in sheep after subcutaneous or conjunctival vaccination.
    Guilloteau LA; Laroucau K; Olivier M; Grillo MJ; Marin CM; Verger JM; Blasco JM
    Vaccine; 2006 Apr; 24(17):3461-8. PubMed ID: 16519974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the use of B. melitensis Rev 1 vaccine in adult sheep and goats.
    Blasco JM
    Prev Vet Med; 1997 Aug; 31(3-4):275-83. PubMed ID: 9234451
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.